Developmental Research Program

发展研究计划

• 批准号: 10226975
• 负责人: David B Solit
• 金额: $ 15.65万
• 依托单位: SLOAN-KETTERING INST CAN RESEARCH
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-08-24 至 2023-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10226975
• 关键词: Address; Advocate; Animals; Area; Cancer Biology; Clinical; Communities; Complement; Development; Diagnosis; Doctor of Philosophy; Early Diagnosis; Etiology; Faculty; Funding; Generations; Goals; Growth; Human; Individual; Institution; International; Intervention; Investigator-Initiated Research; Knowledge; Leadership; Life; Malignant Neoplasms; Malignant neoplasm of urinary bladder; Memorial Sloan-Kettering Cancer Center; Patients; Peer Review; Pelvis; Pilot Projects; Policies; Prevention; Procedures; Prognosis; Public Health; Renal carcinoma; Request for Proposals; Research; Research Personnel; Research Project Grants; Seeds; Testing; Translational Research; Underrepresented Minority; United States; Universities; Ureter Carcinoma; Urothelium; Woman; base; bladder Carcinoma; career; innovation; medical schools; member; preference; programs; symposium

PROJECT SUMMARY/ABSTRACT The goal of the Developmental Research Program (DRP) of the SPORE in Bladder Cancer at Memorial Sloan Kettering Cancer Center (MSK) is to support innovative translational research projects in urothelial cancer by establishing mechanisms for rapid funding. Developmental Research Program funds in the SPORE in Bladder Cancer, supplemented by institutional funds, will allow us to support projects by new and established investigators that are critical to the generation of new ideas in the prevention, diagnosis, and treatment of urothelial cancer. We will request proposals for urothelial cancer pilot projects with translational potential from clinical and basic investigators within the larger MSK community, including Rockefeller University and Weill Cornell Medical College. After rigorous peer review by the DRP Directors, Internal and External Advisory Boards, and the Patient Advocate, the most promising new projects from this wide portfolio of developmental research projects will be selected. Preference will be given to projects that complement the long-term research goals of the SPORE and advance our translational research objectives. The DRP may also solicit and fund experimental or clinical initiatives that address an urgent and specific need in the MSK SPORE in Bladder Cancer program or a unique research opportunity. Eligible pilot project applicants to the DRP must have an MD, MD/PhD, or PhD degree in a relevant area of research, be appointed as faculty members at MSK or affiliated institution (Weill Cornell Medical College, Rockefeller University), demonstrate commitment to an academic career in translational research related to urothelial cancer, and agree to participate in all relevant conferences and activities related to the MSK SPORE in Bladder Cancer for the duration of support. The DRP is committed to adhering to and supporting the MSK policies and procedures to promote diversity and strengthen the participation of women and individuals from underrepresented minorities.

项目概要/摘要 纪念斯隆管理学院膀胱癌 SPORE 发展研究计划 (DRP) 的目标 凯特林癌症中心 (MSK) 将通过以下方式支持尿路上皮癌的创新转化研究项目： 建立快速融资机制。膀胱孢子发育研究计划资金 癌症，在机构资金的补充下，将使我们能够支持新的和已建立的项目 对于产生预防、诊断和治疗新想法至关重要的研究人员 尿路上皮癌。我们将征求具有转化潜力的尿路上皮癌试点项目的提案 MSK 斯隆更大社区内的临床和基础研究人员，包括洛克菲勒大学和威尔大学 康奈尔医学院。经过 DRP 董事严格的同行评审后，内部和外部咨询 委员会和患者倡导者是这个广泛的发展组合中最有前途的新项目 将选择研究项目。将优先考虑补充长期研究的项目 SPORE 的目标并推进我们的转化研究目标。 DRP 还可以征集和资助 解决膀胱 MSK SPORE 的紧急和特定需求的实验或临床举措 癌症计划或独特的研究机会。 DRP 合格试点项目申请人必须拥有 相关研究领域的医学博士、医学博士/哲学博士或博士学位，被任命为 MSK 斯隆的教职人员，或 附属机构（威尔康奈尔医学院、洛克菲勒大学），表现出对 从事与尿路上皮癌相关的转化研究的学术生涯，并同意参加所有相关的 在支持期间参加与 MSK SPORE 膀胱癌相关的会议和活动。发展计划 致力于遵守和支持 MSK 斯隆政策和程序，以促进多样性和 加强妇女和代表性不足的少数群体个人的参与。